MCP: Vaccines Flashcards
1
Q
Influenza Vaccines
A
- Inactivated (IIV)
- Live Attenuated
- FluMist
- Recombinant Hemagglutinin (RIV)
- FluBlock
2
Q
Influenza Egg Allergy
A
- Hives or less: may administer and observe for 30 min
- Intranasal no egg data
- Recombo (FluBlock) is egg free; pt criteria and 18-49 yo
3
Q
Egg Based Trivalent IIV3 (matching)
A
- Afluria, Agriflu, Flarix-IIV3, FluLaval, Fluvirin, Fluzone
4
Q
Egg Based Quadrivalent IIV4
A
- Fluarix
- Additional B coverage
5
Q
Flu Vaccine Schedule and Target Populations
A
- Annual
- 1st time/those not get 2 dose previous year (6mo-8yr), administer 2 dose separated by 4 wk
- High risk population
- greater than 50
- Heart, pulmonary, diabetes, healthcare, preganant, etc.
- Anyone greater than 6 mo
6
Q
Ages and Which Flu Vaccine
A
- Fluzone: indication starts at 6 mo
- Fluzone High Dose >65
- Fluzone ID: 18-64 (10-15 degree vaccine)
7
Q
IIV Flu Vaccine: CI, Precaution, SE,
A
- Contraindications
- Egg allergy/Vaccine Component
- Moderate or severe illness
- Precaution
- GBS in 6 wks
- SE
- Site irriation
- Fever, malasie (rare)
8
Q
LIAV: Name, Target population, SE
A
- FluMist (quadrivalent this year)
- 2-49 yo; high risk populations
- SE: headache, nasal congestion, sore throat
9
Q
LAIV: CI
A
- Severe allergic rxn egg/vaccine
- Moderate/severe illness
- <2 yo or >50, immunocompromised, pregant
- Children <5 with wheezing
- Children on long term aspirin
- Current nasal congestion
10
Q
LAIV: Precaution, Concurrent Admin
A
- Precaution
- GBS in 6 wks
- Avoid severely immunocompromides for 7 days
- Concurrent Admins
- Same day or 4 wks
- TB test >4 wk after live
- LAIV not given until 48 hours after antiviral therapy stopped
- If antiviral in 2 wks of vaccine, redose
11
Q
LAIV: Admin
A
- 1/2 sprayer into each nostril. Sneezing afterwards still confers immunity
- Expiration date
- Remove rubber
- Keep stopper
- Rapid admin
12
Q
RIV: Advantage/Disadvantage
A
- Advantage:
- Fast production in pandemics
- Not depend on egg
- Disadvantage:
- Narrow age (18-49)
- Shorter shelf life (16 wk expire from production date)
13
Q
Shingles: Name, Administartion, Concurrent Admin, Target population/schedul
A
- Zostavax
- Live Vaccine
- Administer SubQ
- Decreased effectiveness if given with PPSV23, but still give
- Adminster other live vaccine 4 wk apart
- Perform TB testing >4 wks
- Population
- 1 dose at >60
- FDA now approve >50
14
Q
Shingles: SE
A
- Local reaciton
- No fever/serious rxn
15
Q
Shingles: Precautions
A
- Current treatment with anti-viral against herpes (acyclovir)
- Avoid antivirral therapy a day before and 14 days after
- Cover any rash
16
Q
Shingles: Contraindication/Storage
A
- Immunosuprresion
- Pregnancy (>4wk)
- Anaphylaxis to vaccine
- Moderate/severe illness
- Storage
- Freezer
- Dilutent at room temp or fridge
- Discard in not used within 30 minutes of reconstitution
17
Q
Shingles Additional Information
A
- Only reduces occurrence of shingles by 50%
- Boosting not recommended
- Proper age range
18
Q
Pneumonia: Who is at most risk
A
- Age 65 or older
- Diabetes Mellitus
- Cancer
- Cigarette smoking
19
Q
Pneumococcal Polysaccharide Vaccine: Name and Example. Who not effective in. What it is for
A
- PPSV23 or Pneumovax
- Capsular Material
- 85-90% cases
- Not effective in <2 yo
- NOT prevent pneumonia but prevent further complications
20
Q
PPSV: Concurrent Adminster, what is type
A
- Potential for decreased shingles
- NOT changed recommendation
- Inactivated bacteria
21
Q
PPSV: Schedule/Revaccination
A
- Schedule:
- Adults 65 or older
- >2 if risks like pulmonary, asplenia, renal failure, immunocompromised
- >19 if asthma/cigs
- Revaccination:
- Routinely not recommended
- Recommended for those >2 at risk of infection
- >65 if recieved first dose before 65
- 5 years after the first dose
22
Q
Pneumonia conjugate vaccine: Name, type, people
A
- PCV13 or Prevnar 13
- Capsular material
- Covalently linked to a nontoxic protein
- Protein helps children regonition
- New recommendtation in adults
- Type: inactivated
23
Q
PCV: Schedule
A
- Children at 2, 4, 6, 12-15 months
- Childern who recieved PPSV23 previously also should recieve the recommended PCV13
24
Q
PCV: Side Effects, CI
A
- SE:
- Local reaction
- Fever, myalgia
- CI:
- Anaphylaxis to vaccine component
- Moderate or severe illness
25
Tdap/Td/DTaP/DT: What the letters mean, who do you give what, concurrent administer
* diptheria and tetanus toxoids (lowercase=reduced toxoid)
* Acceullar pertussis: inactivated bacteria
* Young=All caps
* Older=all lower cases except T
* Concurretn Administer:
* No restriction
26
DTaP
Daptacel, Infanrix, Tripedia
27
Tdap
Adacel, Boostrix
28
Td
Tenivac (Decavac being replaced by Tenivac)
29
DTap Schedule
* 2, 4, 6, 15-18 months
* Completed with same vaccine if possible
30
Boosters of Tdap/Td/DTaP/DT schedule
* DTaP: 4-6 yo prior to school entry
* Tdap: 11-12 yo
* Td every 10 years or Tdap if never had
31
Those who haven't had Tdap yet:
* Adolescents: 11-12 yo
* Adults: 19-64 yo
* Adults 65 yo with contact with infant less than 1 year old
* Tdap instead of Td
* Pregnancy after 20 weeks
* Tdap with EVERY pregnancy
* Healthcare professionals
32
Tdap/Td/DTaP/DT: SE, precautions
* SE:
* Local reaction, Fever
* Precautions:
* Symptoms in 2 days
* Collapse
* 105 fever
* Inconsolable crying for 3 hours
* Convulsions or seizures within 3 days
* Epilepsy
* Arthus type rxn following prior dose
* GBS in 6 wks
33
Tdap/Td/DTaP/DT: CI
* Severe allergic rxn
* Moderate or severe acute illness
* Enecephalophy not attributate to other causes within 7 days administration or previous dose
34
Travel Vaccinations: Type
* Yellow Fever, Typhoid, Japanese Encephalitis
* CDC website for country specific recommendations
